Is this Silicon Valley duo the future of biotech?
SAN FRANCISCO — Seven years ago, Silicon Valley’s brashest venture capitalist invited a soft-spoken Stanford biophysicist out for pancakes not far from here, planning to make a request he publicly swore he’d never make.
By that point, Marc Andreessen had already completed his rise from tech prince — Time magazine literally put him on the cover on a throne in 1996 — to tech kingmaker. The baby-faced founder of Netscape, briefly the world’s dominant web browser, re-emerged in 2009 as head of Andreessen Horowitz, or a16z for short, that quickly became one of the industry’s most sought-after VC firms.
Premium subscription required
Unlock this article along with other benefits by subscribing to one of our paid plans.